Jonathan Appleby
Jonathan Appleby is chief scientific officer, Cell and Gene Therapy Catapult
HSJ PartnersA bright future for genomics and gene therapy in the UK
In a four-part series, bluebird bio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. In this second column, Jonathan Appleby, the Cell and Gene Therapy Catapult’s chief ...